• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合并和未合并肺动脉高压的间质性肺疾病患者的睡眠结构

Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension.

作者信息

Simonson Joseph L, Pandya Dhwani, Khan Sarah, Verma Sameer, Greenberg Harly E, Talwar Arunabh

机构信息

Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 410 Lakeville Road, Suite 107, New Hyde Park, NY, 10040, USA.

Department of Medicine, Northwell Health Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY, 10305, USA.

出版信息

Sleep Breath. 2022 Dec;26(4):1711-1715. doi: 10.1007/s11325-021-02555-1. Epub 2022 Jan 7.

DOI:10.1007/s11325-021-02555-1
PMID:34993759
Abstract

PURPOSE

Sleep disturbance is common in patients with advanced interstitial lung disease (ILD) often complicated by pulmonary hypertension (PH) and may contribute to poor quality of life. The etiology of sleep disturbance and the relationship between PH and sleep architecture in patients with ILD remains unknown.

METHODS

We performed a retrospective cohort study comparing sleep architecture on polysomnography in patients with ILD with and without PH, defined as mean pulmonary artery pressure on right heart catheterization ≥ 20 mmHg. We tested the hypothesis that patients with ILD and PH would have increased wake time after sleep onset (WASO) compared to patients with ILD without PH using univariate analysis and multivariable linear regression.

RESULTS

In our cohort of patients with ILD who underwent polysomnography (N = 49), patients with PH had lower total diffusion capacity for carbon monoxide (DLCO) (9.28 vs. 12.87 ml/min/mmHg, P = 0.04) and percent DLCO (39% vs. 53%, P = 0.03). On polysomnography, patients with PH had increased percentage of total sleep time with saturation < 90% (T90) (17% vs. 6%, P = 0.03), decreased N2 sleep (181 vs. 233 min, P = 0.03), decreased %N2 sleep (59% vs. 66%, P = 0.04), increased %N1 sleep (22% vs. 14%, P = 0.02), decreased sleep efficiency (62% vs. 72%, P = 0.03), and increased WASO (133 vs. 84 min, P = 0.01). In multivariable analysis, PH was associated with a 43-min increase in WASO (95% CI 6.2-80.2, P = 0.02).

CONCLUSION

Patients with ILD and PH have decreased total and %N2 sleep, increased %N1 sleep, decreased sleep efficiency, and increased WASO, likely indicating increased sleep fragmentation.

摘要

目的

睡眠障碍在晚期间质性肺疾病(ILD)患者中很常见,常并发肺动脉高压(PH),并可能导致生活质量下降。ILD患者睡眠障碍的病因以及PH与睡眠结构之间的关系仍不清楚。

方法

我们进行了一项回顾性队列研究,比较了有和没有PH的ILD患者在多导睡眠图上的睡眠结构,PH定义为右心导管检查时平均肺动脉压≥20 mmHg。我们使用单变量分析和多变量线性回归检验了以下假设:与没有PH的ILD患者相比,患有ILD和PH的患者睡眠开始后的清醒时间(WASO)会增加。

结果

在我们接受多导睡眠图检查的ILD患者队列(N = 49)中,患有PH的患者一氧化碳总弥散量(DLCO)较低(9.28 vs. 12.87 ml/min/mmHg,P = 0.04)和DLCO百分比(39% vs. 53%,P = 0.03)。在多导睡眠图上,患有PH的患者总睡眠时间中饱和度<90%(T90)的百分比增加(17% vs. 6%,P = 0.03),N2睡眠减少(181 vs. 233分钟,P = 0.03),N2睡眠百分比降低(59% vs. 66%,P = 0.04),N1睡眠百分比增加(22% vs. 14%,P = 0.02),睡眠效率降低(62% vs. 72%,P = 0.03),以及WASO增加(133 vs. 84分钟,P = 0.01)。在多变量分析中,PH与WASO增加43分钟相关(95% CI 6.2 - 80.2,P = 0.02)。

结论

患有ILD和PH的患者总睡眠和N2睡眠百分比降低,N1睡眠百分比增加,睡眠效率降低,WASO增加,这可能表明睡眠碎片化增加。

相似文献

1
Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension.合并和未合并肺动脉高压的间质性肺疾病患者的睡眠结构
Sleep Breath. 2022 Dec;26(4):1711-1715. doi: 10.1007/s11325-021-02555-1. Epub 2022 Jan 7.
2
Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?新的评分系统能否提高新发间质性肺疾病中肺动脉高压的预测能力?
Lung. 2020 Jun;198(3):547-554. doi: 10.1007/s00408-020-00346-1. Epub 2020 Mar 23.
3
Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.合并和不合并间质性肺疾病的系统性硬化症中重度肺动脉高压的患病率及特征
J Rheumatol. 2007 May;34(5):1005-11. Epub 2007 Apr 15.
4
Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease.夜间低氧血症与间质性肺疾病的不良结局相关。
Respirology. 2019 Oct;24(10):996-1004. doi: 10.1111/resp.13549. Epub 2019 Apr 1.
5
Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.系统性硬皮病相关间质性肺疾病肺动脉高压的临床特征和生存。
Chest. 2011 Oct;140(4):1016-1024. doi: 10.1378/chest.10-2473. Epub 2011 Apr 7.
6
Clinical assessment for pulmonary hypertension in interstitial lung disease.特发性肺纤维化相关肺动脉高压的临床评估。
Intern Med J. 2023 Aug;53(8):1415-1422. doi: 10.1111/imj.15887. Epub 2022 Aug 3.
7
Nocturnal hypoxaemia in interstitial lung disease: a systematic review.间质性肺疾病的夜间低氧血症:系统评价。
Thorax. 2021 Dec;76(12):1200-1208. doi: 10.1136/thoraxjnl-2020-216749. Epub 2021 Apr 29.
8
Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model.脑钠肽(BNP)和超声心动图测量在间质性肺疾病患者肺动脉高压识别中的作用:一种算法应用模型
Respir Med. 2015 Mar;109(3):406-15. doi: 10.1016/j.rmed.2014.12.011. Epub 2015 Jan 3.
9
Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease.肺毛细血管后肺动脉高压对间质性肺疾病死亡率的影响。
Respir Investig. 2021 May;59(3):342-349. doi: 10.1016/j.resinv.2020.12.010. Epub 2021 Feb 10.
10
Pulmonary Hypertension in Interstitial Lung Disease: A Systematic Review and Meta-Analysis.特发性肺纤维化相关肺动脉高压:系统评价和荟萃分析。
Chest. 2024 Oct;166(4):778-792. doi: 10.1016/j.chest.2024.04.025. Epub 2024 May 29.

引用本文的文献

1
The Link Between Sleep-Related Breathing Disorders and Idiopathic Pulmonary Fibrosis: Pathophysiological Mechanisms and Treatment Options-A Review.睡眠相关呼吸障碍与特发性肺纤维化之间的联系:病理生理机制与治疗选择——综述
J Clin Med. 2025 Mar 24;14(7):2205. doi: 10.3390/jcm14072205.

本文引用的文献

1
Sleep and interstitial lung disease.睡眠与间质性肺疾病。
Curr Opin Pulm Med. 2019 Nov;25(6):623-628. doi: 10.1097/MCP.0000000000000620.
2
Sleep as a New Target for Improving Outcomes in Idiopathic Pulmonary Fibrosis.睡眠作为改善特发性肺纤维化预后的新靶点。
Chest. 2017 Dec;152(6):1327-1338. doi: 10.1016/j.chest.2017.07.019. Epub 2017 Aug 1.
3
Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者应接受阻塞性睡眠呼吸暂停的治疗。
Sleep Breath. 2015 Mar;19(1):385-91. doi: 10.1007/s11325-014-1033-6. Epub 2014 Jul 16.
4
Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者的睡眠质量及相关的日间后果
Med Princ Pract. 2009;18(1):10-5. doi: 10.1159/000163039. Epub 2008 Dec 4.
5
Breathing during sleep in patients with interstitial lung disease.
Am Rev Respir Dis. 1985 Aug;132(2):224-9. doi: 10.1164/arrd.1985.132.2.224.